As of 2025-05-15, the EV/EBITDA ratio of Palla Pharma Ltd (PAL.AX) is -2.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PAL.AX's latest enterprise value is 62.42 mil AUD. PAL.AX's TTM EBITDA according to its financial statements is -21.53 mil AUD. Dividing these 2 quantities gives us the above PAL.AX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 12.6x | 12.2x |
| Forward P/E multiples | 10.7x - 13.1x | 11.6x |
| Fair Price | (1.61) - (1.77) | (1.68) |
| Upside | -646.5% - -699.7% | -668.3% |
| Date | EV/EBITDA |